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Short Report
Retrospective Review of the use of Swan Ganz Catheters in our Intensive Care
Unit (ICU): a Short Report
Shahla Siddiqui
Department of Anaesthesia and Critical Care, The Aga Khan University Hospital, Karachi.
Abstract
The widespread and often 'misuse' of the Swan Ganz
(SG) or Pulmonary artery catheter has often been seen in
intensive care patients. The objective of this preliminary
review was to observe the trends and possibly formulate an
association with outcome of the use of SG catheters as well as
to determine the frequency of use and possible complications.
The chart review of ten patients was carried out for
the months of January and February 2004 in a retrospective
manner. The incidence of SG catheter insertion was 12%
per month on average. Nine out of 10 patients received the
SG catheters for 'fluid management'; and 1 for 'haemody-
namic instability'. Eight out of 10 patients expired and aver-
age length of stay was 9 days. There were no complications
recorded. The cause of death in all patients was 'severe sep-
sis'. The overwhelming majority of patients who received
these catheters expired at the end of their stay.
Introduction
Existing randomized controlled trials on SG
catheter-guided strategies reveal a modest risk reduction
that does reach statistical significance.  Risk reduction
appears to be greatest in surgical series.1 The procedure
commonly includes insertion of a flexible, balloon-tipped
catheter into the pulmonary artery for haemodynamic mon-
itoring of the critically ill patient.2 This is primarily insert-
ed for patients with systemic shock requiring haemodynam-
ic support. However the efficacy of data collected from its
use is debatable.3,4 The safety of pulmonary artery catheter-
ization has been questioned.5 Most clinicians believe that
PAC use is beneficial in guiding therapy and may improve
outcome. Despite these beliefs and hundreds of published
articles related to SG catheters, appropriate use and impact
on outcome remain unclear.6 Direct pressure measurements
are obtained in the respective cardiac chambers and pul-
monary artery. An indirect measurement of left atrial filling
pressure is obtained when the catheter is "wedged". In addi-
tion, other haemodynamic parameters may be easily meas-
ured, such as the cardiac output, systemic vascular resist-
ance (SVR), mixed venous oxygen saturation, and intrapul-
monary shunt fraction.7 Many studies have been done in the
West looking at similar parameters as ours in their setting.8
However, given the high cost of intensive care and monitor-
ing and doubtful improvement in outcome, we wished to
embark on a retrospective review to observe, the frequency
of SG catheter use, and indications for SG catheter use in
our ICU. Correlation with length of stay (days), outcome of
the patient and complications, if any were also noted. 
Methods and Results
A retrospective chart review was carried out on all
patients who had a SG catheter placed whilst in the ICU from
January 1st - February 28th 2005. Inclusion criteria was all
adults (above the age of 18) receiving SG catheters.
Exclusion criteria were all paediatric patients and post car-
diopulmonary resuscitation (CPR) patients. The setting was a
12 bedded multidisciplinary intensive care unit of a tertiary
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care university hospital.  The parameters noted were frequen-
cy of use, indications of use, length of stay, outcome and
complications. Results are shown in table. The frequency of
use was in 12 % patients per month; fluid management was
the indication in 90% cases; 9 days were the average length
of stay in the ICU and 80% expired due to severe sepsis. No
complications were reported. Despite being a small sample
size, we have found no conclusive evidence that use of Swan
Ganz catheter improves survival in any way.
Table. Review of Swan Ganz Catheter outcomes.
Comments
Most clinicians believe that SG catheter use is bene-
ficial in guiding therapy and may improve outcome.9
Access to haemodynamic data provided by the SG catheter,
coupled with accurate interpretation of the data, may lead to
reduced peri-operative morbidity and mortality.  Although it
may be used for 'fluid monitoring alone, many assumptions
have to be fulfilled first which are often not present in crit-
ically ill patients.3,4 These include absence of pulmonary or
left ventricular dysfunction.
However, its use is associated with life-threatening
complications such as Line sepsis, cardiac rupture, pul-
monary artery rupture, cardiac tamponade, among others, if
not recognized and treated early. The cost of inserting and
monitoring these catheters is also high. As Critical care
moves towards a more technologically dependent era, we
must carefully consider the downside of using maneuvers
which will not be of benefit and could possibly harm the
patient including increasing the resources utilized.10 There
are very few large randomized studies done to justify the
use of SG catheters and until then it is at best a means of
providing a "guestimate" of the fluid status of a patient. We
recommend a careful reevaluation, including designing a
prospective controlled study in our environment to look at
the efficacy of these catheters in the future. Clinical exami-
nation and judgement must not ever replace the "numbers"
obtained and their often misread interpretation and meas-
urement by the ICU staff.
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Patient No. Indication             Length of Outcome          Complication
stay (days)
January
1. Fluid management       18 Expired: None reported
severe sepsis
2. Fluid management 9 Expired: None reported
severe sepsis
3. Fluid management 1 Expired: None reported
severe sepsis
4. Fluid management 17 Discharged None reported
to floor
5. Haemodynamic 7 Expired: None reported
instability severe sepsis
6. Fluid management 6 Expired: None reported
severe sepsis
February
7. Fluid management 11 Expired: None reported
severe sepsis
8. Fluid management 11 Expired: None reported
severe sepsis
9. Fluid management 6 Discharged None reported
to floor
10. Fluid management 4 Expired: None reported
severe sepsis
